Infusion Therapy Market – Trends Forecast Till 2030

Market Snapshot

Market Overview

The global Infusion Therapy Market size is projected to reach a CAGR of 7% from 2023-2030.

Infusion therapy is an alternative to oral treatment that involves the administration of drugs/medicine and nutrition through a sterile catheter or needle. It is usually employed to treat serious or chronic infections that do not respond to oral medications. The therapy is performed at hospitals, infusion therapy centers, or homes and involves the administration of medication via catheters or needles by specially trained professionals such as nurses. Infusion therapy services are commonly employed in the treatment of cancer, gastrointestinal (GI) disorders, dehydration caused by nausea, vomiting, diarrhea, heart failure, chronic pain, and immune system problems.

Infusion therapy services are also utilized in the treatment of rheumatoid arthritis, Crohn’s disease, immune deficiencies, hemophilia, and multiple sclerosis. Hence, an increase in application areas of infusion therapy creates a significant opportunity for companies to expand their services. This, in turn, is projected to drive the global infusion therapy market. Other factors which will propel the market are the rise in the number of people suffering from chronic pain, cancer, and diabetes. Governments in developing countries are making significant investments to modernize healthcare infrastructure, which is likely to increase access to healthcare. This is expected to increase the demand for infusion therapy services. The rise in the prevalence of chronic diseases in developing countries presents lucrative opportunities in the global infusion therapy market

On the other hand, associated risks during the administration of medication, irregularity in the functioning of infusion devices, misguided use of infusion devices, and complex reimbursement policies, may hamper the growth of the market.

As cases of COVID-19 been increasing in 2020, the use of alternate site solutions rose in high demand, and home and specialty infusion providers played a critical role in supporting patients. In April 2020, the American Society of Clinical Oncology (ASCO) issued guidelines for infusion therapies for hospital and home infusion services, to ensure the safety of patients. The American Society of Clinical Oncology (ASCO) reported that there might be rare circumstances of risks with home infusion therapies that could need immediate medical necessities. In these highly unusual situations, the increased risk of a home infusion may be outweighed by the risks associated with the lack of access to biological therapy.

Delvens Industry Expert's Standpoint

The infusion therapy market is poised for substantial growth, driven by the increasing demand for advanced and personalized therapies, the rising prevalence of chronic diseases, and the growing geriatric population. However, overcoming challenges related to cost, reimbursement, and adverse effects of infusion therapy will be crucial for sustained market expansion. With the right strategies and innovations, players in the infusion therapy market are well-positioned to capitalize on the opportunities and shape the future of healthcare delivery.

Market Portfolio

Key Findings

• The anti-infective therapy segment is expected to dominate the global home infusion therapy market through the forecast period. Anti-infective therapy is one of the most prescribed home infusion therapies. However, there are few risks intrinsic to such therapy, which can be reduced by a team approach, coupled with careful patient selection criteria, a structured follow-up process, and an emphasis on patient education.
   
• Home infusion anti-infective therapy can be indicated for various types of infections such as Catheter sepsis, Cellulitis, Chronic urinary tract infections (UTI), Pneumonia, Cystic fibrosis (CF), and Fungal infections.
   
• Moreover, market players are adopting various inorganic growth strategies to gain a competitive edge. For instance, in October 2018, Shift Labs entered into a collaboration with New England Life Care (NELC), a leading regional provider of home infusion services throughout northern New England, to expand its footprint in the home and alternate site infusion market.

Regional Analysis

North America to Dominate the Market

• On the other hand, the infusion therapy market in North America is expanding at a rapid pace due to the high incidence rate of chronic diseases such as diabetes and cardiovascular diseases. Also, Asia Pacific is estimated to expand at a rapid pace during the forecast period owing to a rise in healthcare infrastructure. Moreover, the surge in the geriatric population coupled with chronic diseases is likely to propel the market in the region.
   
• The infusion therapy market in Latin America and the Middle East & Africa is projected to expand at a steady pace due to a rise in the demand for low-cost infusion therapy in these regions.